Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study
CNR Ibb | back to homepage